Number 112, Jul. 2018
Mr. Seiichi Sato, appointed as the 13th Chairman of JSMI, announced the administrative policies
In the 222nd meeting of the board of directors held on April 20, JSMI appointed Mr. Seiichi Sato (President and CEO, Sato Pharmaceutical Co., Ltd.) as the new chairman following the resignation of the former chairman Mr. Masashi Sugimoto. Chairman Sato announced the following administrative policies for fiscal 2018 in the press conference held after the general meeting on May 21:........MORE>>
Back Number
Introduction Organization  
  Country Profile of Japan JSMI Newsletter
  Self-medication Handbook JSMI Member Companies

ITOHPIA Iwamotocho 1-chome Bldg. 4th Floor 1-8-15 Iwamotocho,
Chiyoda-ku, Tokyo 101-0032 JAPAN
E-mail :